CARMEL, Ind., Oct. 22, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced that the...
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
New Trading Symbol "NAYA" Effective Tuesday October 22, 2024SARASOTA, Fla. and MIAMI, Oct. 21, 2024 -- INVO Biosciences (Nasdaq: INVO), a company focused on expanding its portfolio of clinical and commercial-stage assets in fertility, oncology, and autoimmune diseases...
Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System
CARLSBAD, Calif., Oct. 15, 2024 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has launched its new OSTEO...
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
DENVER, CO / October 14, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced Josh Disbrow, Chief Executive Officer of Aytu, will participate in a fireside chat at...
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseasesSARASOTA, Fla. and MIAMI, Oct. 14, 2024 -- INVO Bioscience ("INVO") (NASDAQ: INVO) today announced it has closed its merger with NAYA...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
PORTLAND, Maine, Oct. 08, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
DUBLIN, Oct. 07, 2024 -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the successful completion of its first pre-pivotal...
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
WINTER SPRINGS, Fla., Oct. 03, 2024 -- IRADIMED CORPORATION ("Iradimed") (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that it will participate in the 3rd Annual ROTH Healthcare...
Mobile-health Network Solutions (MNDR) Fireside Chat
Mobile-health Network Solutions (Nasdaq: MNDR) is a leading Asia-Pacific telehealth provider. Ranked #41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies, MNDR is the first telehealth provider from the Asia-Pacific region to be listed in...
Fortress Biotech (FBIO) Company Webcast
Fortress Biotech, Inc. (Nasdaq: FBIO) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue. The company has seven...